Early-onset venous thromboembolisms in newly diagnosed non-promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapy.

Sebastian E Koschade Jan A StratmannBjörn SteffenShabnam ShaidFabian Finkelmeier Hubert Serve Wolfgang Miesbach Christian H Brandts Olivier Ballo

Published in: European journal of haematology (2023)

Early-onset VTE is a common complication in newly diagnosed AML patients admitted for induction chemotherapy. Leukocytosis is an independent VTE risk factor. The potentially adverse impact of non-CVC-related VTE merits further study.

Keyphrases

early onset
newly diagnosed
venous thromboembolism
acute myeloid leukemia
late onset
patients undergoing
locally advanced
risk factors
allogeneic hematopoietic stem cell transplantation
squamous cell carcinoma
emergency department
chemotherapy induced
electronic health record
adverse drug